简体中文 | 繁體中文 | English

Products & Services News

2016-12-06 17:17 Philip Morris International (PMI) Announces Filing of Application for Its Electronically Heated Tobacco Product with the US Food and Drug Administration (FDA)
2016-12-06 16:09 CHINAPLAS to Choreograph 3 Great Concurrent Events A Place for Global Giants to Unveil Industrial Trends
2016-12-06 15:22 U.S. FDA approves Jardiance® (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
2016-12-06 14:55 Amano Dental Clinic (Japan) Launches Tooth Brushing App "Brush'n'Save" Created by Active Dentist to Ensure Cavity-Free Life for His Daughter
2016-12-06 14:44 BTIG Announces Blackstone Tactical Opportunities Strategic Investment
2016-12-06 12:08 BoardPad for Android Has Arrived
2016-12-06 10:44 I-Promotions Limited Puts Potential-Rich Casino.cn Domain Name up for Sale
2016-12-06 10:11 MegaChips Adopts Omni Design’s Ultra-Low Power Analog-to-Digital Converter Front-Ends for Next-Generation Communication Networks
2016-12-06 09:59 Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic Leukaemia
2016-12-05 17:42 Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases
2016-12-05 17:16 Visa to Acquire CardinalCommerce to Secure and Accelerate Digital Commerce
2016-12-05 16:57 New Data Show High Adherence Rates with Pradaxa® (dabigatran etexilate) in NVAF Patients
2016-12-05 16:49 SES Adds 24/7 4KUNIVERSE Ultra HD Channel
2016-12-05 15:24 Hilton’s Curio Collection Premieres in New York City with Art-Deco Renwick Hotel
2016-12-05 15:11 Panasonic Develops Industry's First*1 IPS Liquid Crystal Panel with Contrast Ratio of over 1,000,000:1
2016-12-05 14:58 Hilton Hotels & Resorts Debuts in Heart of Brooklyn
2016-12-05 14:29 Bitmovin Releases First End-to-End Video Infrastructure API for Developers
2016-12-05 10:39 Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma
2016-12-05 10:24 NTT Communications to Highlight Network Security and Innovation at Capacity Asia 2016 Conference
2016-12-02 18:57 GVK BIO Announces Launch of a GMP Compliant Analytical Services Laboratory